Aprea Therapeutics APRE
NASDAQ APRE
$0.51 -0.03 (-5.41%)
As of: Oct 23, 2026 · 3:59 PM EDT

Aprea Therapeutics (APRE) Price to Sales (2019 - 2026)

Updated

Analysis

Aprea Therapeutics (APRE) Price to Sales (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Aprea Therapeutics 27.54 Mn -88.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 56.07
Mar 31, 2026 15.64
Dec 31, 2025 8.52
Sep 30, 2025 10.95
Jun 30, 2025 9.66
Mar 31, 2025 9.29
Dec 31, 2024 13.99
Sep 30, 2024 11.28
Jun 30, 2024 17.04
Mar 31, 2024 22.45
Dec 31, 2023 14.35
Sep 30, 2023 13.47
Jun 30, 2023 11.91
Mar 31, 2023 23.56
Dec 31, 2022 24.45
Sep 30, 2022 107.83
Jun 30, 2022 303.89
Mar 31, 2022 8,740.85
Dec 31, 2021 38,068.29
Sep 30, 2021 35,600.23
API Access

Aprea Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=APRE&period=max&api_key=YOUR_API_KEY